DBTX
$4.59
Decibel Therapeutics
($.07)
(1.50%)
DBTX
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.50)
Revenue:  $2.00 Mil
Wednesday
Feb 9
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when DBTX reports earnings?
Beat
Meet
Miss

Where is DBTX's stock price going from here?
Up
Flat
Down
Stock chart of DBTX
Analysts
Summary of analysts' recommendations for DBTX
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Decibel Therapeutics is a clinical-stage biotechnology company. It engages in discovering and developing transformative treatments to restore and improve hearing and balance. Decibel Therapeutics is based in BOSTON.